HighVista Strategies’s Relmada Therapeutics RLMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q1 | – | Sell |
-26,299
| Closed | -$91.8K | – | 130 |
|
|
2022
Q4 | $91.8K | Sell |
26,299
-3,764
| -13% | -$13.1K | 0.05% | 105 |
|
|
2022
Q3 | $1.11M | Buy |
30,063
+570
| +2% | +$21.1K | 0.64% | 39 |
|
|
2022
Q2 | $560K | Buy |
29,493
+8,112
| +38% | +$154K | 0.34% | 72 |
|
|
2022
Q1 | $577K | Buy |
+21,381
| New | +$577K | 0.37% | 68 |
|
|
2021
Q1 | – | Sell |
-22,450
| Closed | -$720K | – | 137 |
|
|
2020
Q4 | $720K | Buy |
22,450
+9,885
| +79% | +$317K | 0.46% | 52 |
|
|
2020
Q3 | $473K | Buy |
12,565
+2,872
| +30% | +$108K | 0.34% | 55 |
|
|
2020
Q2 | $434K | Buy |
+9,693
| New | +$434K | 0.36% | 38 |
|